Accendra Health (NYSE:ACH – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.18), FiscalAI reports. The firm had revenue of $601.77 million for the quarter. Accendra Health had a negative net margin of 11.41% and a negative return on equity of 4.02%.
Accendra Health Trading Down 27.7%
Accendra Health stock traded down $0.08 during midday trading on Friday, reaching $0.22. The stock had a trading volume of 1,665,980 shares, compared to its average volume of 1,397,597. The company has a fifty day moving average price of $0.64 and a two-hundred day moving average price of $2.13. Accendra Health has a 12 month low of $0.19 and a 12 month high of $4.69. The company has a market capitalization of $16.59 million, a P/E ratio of -0.06 and a beta of 1.60.
Wall Street Analysts Forecast Growth
ACH has been the topic of a number of recent analyst reports. Citigroup downgraded Accendra Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $4.50 to $1.50 in a research note on Monday, August 10th. UBS Group decreased their target price on Accendra Health from $4.50 to $1.50 and set a “neutral” rating for the company in a research note on Thursday, August 13th. Robert W. Baird cut Accendra Health from an “outperform” rating to a “neutral” rating and set a $1.50 target price for the company. in a research note on Tuesday, August 11th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Accendra Health in a report on Tuesday. Finally, Zacks Research upgraded Accendra Health from a “strong sell” rating to a “hold” rating in a report on Tuesday. Four analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Accendra Health has a consensus rating of “Reduce” and a consensus price target of $1.50.
Read Our Latest Analysis on ACH
Institutional Investors Weigh In On Accendra Health
A number of hedge funds have recently added to or reduced their stakes in ACH. Walleye Capital LLC bought a new stake in Accendra Health during the 1st quarter valued at $27,000. Hsbc Holdings PLC acquired a new position in Accendra Health during the first quarter worth $34,000. Corient Private Wealth LP bought a new position in shares of Accendra Health in the second quarter valued at $40,000. Abel Hall LLC bought a new position in shares of Accendra Health in the first quarter valued at $44,000. Finally, Keybank National Association OH bought a new position in shares of Accendra Health in the first quarter valued at $46,000.
Accendra Health Company Profile
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.
Featured Stories
- Five stocks we like better than Accendra Health
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
- Block by Block: Cash App Builds a Stronger Foundation
Receive News & Ratings for Accendra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accendra Health and related companies with MarketBeat.com's FREE daily email newsletter.
